Total Assets Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd.'s latest annual total assets in 2023 was 3.62 Billion CNY , up 1.49% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd.'s latest quarterly total assets in 2024 Q1 was 3.41 Billion CNY , down -5.85% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported annual total assets of 3.56 Billion CNY in 2022, up 4.92% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported annual total assets of 3.4 Billion CNY in 2021, up 13.73% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported quarterly total assets of 3.5 Billion CNY for 2024 Q2, up 2.74% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported quarterly total assets of 3.51 Billion CNY for 2024 Q3, up 0.4% from previous quarter.

Annual Total Assets Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Total Assets	Total Assets Growth
2023	3.62 Billion CNY	1.49%
2022	3.56 Billion CNY	4.92%
2021	3.4 Billion CNY	13.73%
2020	2.99 Billion CNY	6.61%
2019	2.8 Billion CNY	1.63%
2018	2.76 Billion CNY	12.52%
2017	2.45 Billion CNY	10.68%
2016	2.21 Billion CNY	13.97%
2015	1.94 Billion CNY	170.73%
2014	718.34 Million CNY	32.77%
2013	541.04 Million CNY	36.93%
2012	395.13 Million CNY	41.24%
2011	279.76 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	3.41 Billion CNY	-5.85%
2024 Q2	3.5 Billion CNY	2.74%
2024 Q3	3.51 Billion CNY	0.4%
2023 Q4	3.62 Billion CNY	-2.21%
2023 FY	3.62 Billion CNY	1.49%
2023 Q1	3.54 Billion CNY	-0.57%
2023 Q2	3.77 Billion CNY	6.45%
2023 Q3	3.7 Billion CNY	-1.94%
2022 Q1	3.47 Billion CNY	2.2%
2022 Q3	3.57 Billion CNY	0.67%
2022 Q4	3.56 Billion CNY	-0.05%
2022 Q2	3.54 Billion CNY	2.03%
2022 FY	3.56 Billion CNY	4.92%
2021 Q3	3.04 Billion CNY	0.77%
2021 Q4	3.4 Billion CNY	11.54%
2021 Q2	3.02 Billion CNY	0.07%
2021 FY	3.4 Billion CNY	13.73%
2021 Q1	3.02 Billion CNY	1.1%
2020 FY	2.99 Billion CNY	6.61%
2020 Q2	2.89 Billion CNY	2.58%
2020 Q4	2.99 Billion CNY	1.38%
2020 Q3	2.95 Billion CNY	2.06%
2020 Q1	2.81 Billion CNY	0.45%
2019 Q4	2.8 Billion CNY	1.39%
2019 FY	2.8 Billion CNY	1.63%
2019 Q1	2.69 Billion CNY	-2.22%
2019 Q2	2.69 Billion CNY	-0.26%
2019 Q3	2.76 Billion CNY	2.77%
2018 Q1	2.53 Billion CNY	3.41%
2018 FY	2.76 Billion CNY	12.52%
2018 Q4	2.76 Billion CNY	6.34%
2018 Q3	2.59 Billion CNY	3.62%
2018 Q2	2.5 Billion CNY	-1.26%
2017 Q4	2.45 Billion CNY	5.18%
2017 Q1	2.22 Billion CNY	0.49%
2017 FY	2.45 Billion CNY	10.68%
2017 Q2	2.23 Billion CNY	0.54%
2017 Q3	2.33 Billion CNY	4.15%
2016 Q3	2.1 Billion CNY	3.34%
2016 Q4	2.21 Billion CNY	5.43%
2016 Q2	2.03 Billion CNY	1.45%
2016 FY	2.21 Billion CNY	13.97%
2016 Q1	2 Billion CNY	3.11%
2015 Q2	1.82 Billion CNY	164.98%
2015 FY	1.94 Billion CNY	170.73%
2015 Q4	1.94 Billion CNY	3.54%
2015 Q3	1.87 Billion CNY	2.91%
2015 Q1	688.76 Million CNY	-4.12%
2014 FY	718.34 Million CNY	32.77%
2014 Q1	- CNY	0.0%
2014 Q4	718.34 Million CNY	0.0%
2013 FY	541.04 Million CNY	36.93%
2012 FY	395.13 Million CNY	41.24%
2011 FY	279.76 Million CNY	0.0%

Peer Total Assets Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.

Name	Total Assets	Total Assets Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	32.3 Billion CNY	88.787%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.39 Billion CNY	17.515%
Dong-E-E-Jiao Co.,Ltd.	13.3 Billion CNY	72.778%
Livzon Pharmaceutical Group Inc.	25.04 Billion CNY	85.537%
Hainan Haiyao Co., Ltd.	7.36 Billion CNY	50.829%
Tus-Pharmaceutical Group Co., Ltd.	1.15 Billion CNY	-214.667%
Jilin Aodong Pharmaceutical Group Co., Ltd.	32.26 Billion CNY	88.774%
Changchun High-Tech Industries (Group) Inc.	30.74 Billion CNY	88.218%
Apeloa Pharmaceutical Co.,Ltd	12.76 Billion CNY	71.63%
PKU HealthCare Corp.,Ltd.	2.43 Billion CNY	-48.555%
Chengdu Huasun Technology Group Inc., Ltd.	2.13 Billion CNY	-69.779%
Dezhan Healthcare Company Limited	5.37 Billion CNY	32.655%
Jinling Pharmaceutical Company Limited	4.55 Billion CNY	20.4%
Jiuzhitang Co., Ltd.	5.32 Billion CNY	32.039%
Huapont Life Sciences Co., Ltd.	30.72 Billion CNY	88.212%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	7.98 Billion CNY	54.646%
Shandong Wohua Pharmaceutical Co., Ltd.	1.14 Billion CNY	-216.431%
Hengkang Medical Group Co., Ltd.	6.08 Billion CNY	40.426%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	6.45 Billion CNY	43.916%
Qianjiang Yongan Pharmaceutical Co., Ltd.	2.34 Billion CNY	-54.324%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	19.2 Billion CNY	81.138%
Jinhe Biotechnology CO., LTD.	5.45 Billion CNY	33.584%
Teyi Pharmaceutical Group Co.,Ltd	2.51 Billion CNY	-44.159%
Kunming Longjin Pharmaceutical Co., Ltd.	631.63 Million CNY	-473.465%
Beijing Aosaikang Pharmaceutical Co., Ltd.	3.52 Billion CNY	-2.79%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	8.52 Billion CNY	57.534%
Anhui Huangshan Capsule Co., Ltd.	1.1 Billion CNY	-228.37%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	2.12 Billion CNY	-70.455%
Zhuhai Rundu Pharmaceutical Co., Ltd.	2.22 Billion CNY	-62.593%
Huaren Pharmaceutical Co., Ltd.	5.16 Billion CNY	29.88%
Tianjin Ringpu Bio-Technology Co.,Ltd.	6.59 Billion CNY	45.084%
Shanxi Zhendong Pharmaceutical Co.,Ltd	6.18 Billion CNY	41.393%
Fuan Pharmaceutical (Group) Co., Ltd.	5.97 Billion CNY	39.387%
Hybio Pharmaceutical Co., Ltd.	3.27 Billion CNY	-10.528%
Baotou Dongbao Bio-Tech Co.,Ltd	2.74 Billion CNY	-32.1%
Hunan Er-Kang Pharmaceutical Co., Ltd	5.47 Billion CNY	33.89%
Changjiang Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	-5.121%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	5.26 Billion CNY	31.145%
Fujian Cosunter Pharmaceutical Co., Ltd.	1.61 Billion CNY	-124.357%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	930.4 Million CNY	-289.314%
Hainan Poly Pharm. Co., Ltd	6.28 Billion CNY	42.383%
Jiangxi Synergy Pharmaceutical Co., Ltd.	3.22 Billion CNY	-12.44%
Wuhan Hiteck Biological Pharma Co.,Ltd	2.97 Billion CNY	-21.908%
Shandong Xinhua Pharmaceutical Company Limited	8.35 Billion CNY	56.643%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	6.33 Billion CNY	42.851%
PharmaBlock Sciences (Nanjing), Inc.	5.1 Billion CNY	29.033%
Jinghua Pharmaceutical Group Co., Ltd.	3.18 Billion CNY	-13.726%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	7.52 Billion CNY	51.833%
Betta Pharmaceuticals Co., Ltd.	9.14 Billion CNY	60.4%
Tibet AIM Pharm. Inc.	927.74 Million CNY	-290.431%
Shenzhen Kangtai Biological Products Co., Ltd.	15.08 Billion CNY	75.989%
Shandong Shanda Wit Science and Technology Co., Ltd.	5.19 Billion CNY	30.319%
Pacific Shuanglin Bio-pharmacy Co., LTD	8.63 Billion CNY	58.03%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	3.01 Billion CNY	-19.941%
Xiamen Kingdomway Group Company	5.35 Billion CNY	32.338%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	1.43 Billion CNY	-152.757%
Walvax Biotechnology Co., Ltd.	15.58 Billion CNY	76.764%
Sunflower Pharmaceutical Group Co.,Ltd	6.88 Billion CNY	47.366%
Harbin Gloria Pharmaceuticals Co., Ltd	3.15 Billion CNY	-14.901%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	40.14 Billion CNY	90.978%
Hunan Hansen Pharmaceutical Co., Ltd.	2.33 Billion CNY	-55.028%
Changzhou Qianhong Biopharma CO.,LTD	2.76 Billion CNY	-30.951%
Shenzhen Weiguang Biological Products Co., Ltd.	2.87 Billion CNY	-25.912%
Honz Pharmaceutical Co., Ltd.	2.16 Billion CNY	-67.259%
Northeast Pharmaceutical Group Co., Ltd.	15.27 Billion CNY	76.285%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	4.52 Billion CNY	19.869%
Guizhou Xinbang Pharmaceutical Co., Ltd.	9.24 Billion CNY	60.82%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	5.78 Billion CNY	37.339%
Zhejiang Yatai Pharmaceutical Co., Ltd.	1.42 Billion CNY	-153.412%
Zhejiang NHU Company Ltd.	39.15 Billion CNY	90.749%
ApicHope Pharmaceutical Co., Ltd	4.4 Billion CNY	17.776%
Shanghai Kaibao Pharmaceutical CO.,Ltd	4.57 Billion CNY	20.907%
Beijing SL Pharmaceutical Co., Ltd.	6.27 Billion CNY	42.301%
Yunnan Baiyao Group Co.,Ltd	53.78 Billion CNY	93.265%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.33 Billion CNY	-170.991%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	1.54 Billion CNY	-134.795%
Guangdong Lifestrong Pharmacy Co., Ltd.	855.53 Million CNY	-323.384%
Huadong Medicine Co., Ltd	33.5 Billion CNY	89.19%
Jiangsu Nhwa Pharmaceutical Co., LTD	7.32 Billion CNY	50.572%
Harbin Medisan Pharmaceutical Co., Ltd.	3.44 Billion CNY	-5.205%
LanZhou Foci Pharmaceutical Co.,Ltd.	2.52 Billion CNY	-43.278%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	11.83 Billion CNY	69.394%
Beijing Beilu Pharmaceutical Co., Ltd	2.81 Billion CNY	-28.473%
Nanjing Hicin Pharmaceutical Co., Ltd.	1.41 Billion CNY	-155.283%
Renhe Pharmacy Co., Ltd.	7.44 Billion CNY	51.345%
Chongqing Pharscin Pharmaceutical Co., Ltd.	1.85 Billion CNY	-95.641%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	6.99 Billion CNY	48.201%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	5.11 Billion CNY	29.218%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	7.34 Billion CNY	50.712%

Global Stocks Search

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)

Total Assets Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Annual Total Assets Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Total Assets Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.